Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
FDA regulatory context: As of May 2026, the FDA has proposed excluding compounded semaglutide and tirzepatide from the 503B Bulks List, with a public comment period closing June 29, 2026
However, they differed on the exposure time: 24 h [111] or 48 h [112]
Preliminary checks found the product contained Glutathione a substance listed under the in the Drug Registration Guidance Document (DRGD), meaning it is not permitted for use in food supplements
inhibition of reactive oxygen species-producing enzymes such as xanthine oxidase (XO) and nicotinamide adenine dinucleotide phosphate oxidase (NOX)
US$ 27.17
US$ 28.33
US$ 28.22
US$ 23.89
US$ 29.03
US$ 21.28
US$ 22.05
US$ 27.35
US$ 25.09
US$ 26.24
